Tilray Brands NASDAQ: TLRY shareholders re-elected three directors and ratified the company's auditor at its annual meeting, but a proposal to declassify the board fell short of the required support despite receiving a majority of votes cast.
Tilray started out as a pure-play cannabis company. Today, Tilray sells more alcohol than cannabis, as it has transformed into a diversified consumer staples company.
Tilray Brands stock extended its sell-off this week, sinking to a record low as concerns about the company intensified. The shares fell to $2.34, leaving them down 74% so far this year, 55% over the past six months, and 98% over the past five years.
A Fresh Way to Experience Breckenridge Distillery Through Special Bottlings, Tastings and Behind-The-Scenes Access A Fresh Way to Experience Breckenridge Distillery Through Special Bottlings, Tastings and Behind-The-Scenes Access
Rescheduling marijuana to a lower level makes the substance easier to research and results in lower tax bills for companies. Tilray, however, is a Canadian producer and won't directly see any benefits from rescheduling.
Tilray is consolidating its operations in Canada to simplify its business and achieve cost savings. The company announced new guidance for adjusted EBITDA that is slightly higher at the low end than before.
Zacks.com users have recently been watching Tilray Brands (TLRY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Consolidation of Foss Cultivation and Pre-roll Production into Optimized Masson and Cayuga Facilities Expected to Generate Approximately US$10 Million in Annualized Cost Savings Higher Cultivation Yields and Expected Reestablishment of EU-GMP Certification Strengthen Tilray's Canadian Cannabis Platform and Position the Business for Continued Growth in Canada, International Markets, and Future U.S. Medical Cannabis Markets When Permissible Tilray Raises Fiscal 2027 Adjusted EBITDA Guidance to $70 Million–$75 Million, Increasing the Lower End of the Range NEW YORK and LONDON and LEAMINGTON, Ontario, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company with leading positions across cannabis, beverage, hospitality and wellness, today announced plans to consolidate its Canadian cannabis operations, transitioning cultivation and pre-roll production from its Foss facility in Fenwick, Ontario to its Masson, Quebec and Cayuga, Ontario facilities. This strategic initiative is expected to generate approximately US$10 million in annualized cost savings by the end of fiscal 2028.